Skip to content
← Back to this collection

PUBLICATIONS · 36779385

Neoadjuvant pazopanib in nonrhabdomyosarcoma soft tissue sarcomas (ARST1321): A report of major wound complications from the Children's Oncology Group and NRG Oncology.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Surg Oncol
Publication date
2023 Apr
First author
Kayton ML

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Kayton ML
      type
      Author
    2. name
      Weiss AR
      type
      Author
    3. name
      Xue W
      type
      Author
    4. name
      Binitie O
      type
      Author
    5. name
      Hayes Dixon A
      type
      Author
    6. name
      Randall RL
      type
      Author
    7. name
      Sorger JI
      type
      Author
    8. name
      Hawkins DS
      type
      Author
    9. name
      Spunt SL
      type
      Author
    10. name
      Wang D
      type
      Author
    11. name
      Million L
      type
      Author
    12. name
      Terezakis S
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Kayton ML
      type
      Author
    2. name
      Weiss AR
      type
      Author
    3. name
      Xue W
      type
      Author
    4. name
      Binitie O
      type
      Author
    5. name
      Hayes Dixon A
      type
      Author
    6. name
      Randall RL
      type
      Author
    7. name
      Sorger JI
      type
      Author
    8. name
      Hawkins DS
      type
      Author
    9. name
      Spunt SL
      type
      Author
    10. name
      Wang D
      type
      Author
    11. name
      Million L
      type
      Author
    12. name
      Terezakis S
      type
      Author
    bibliography ids
    1. nci-bib-464875efe7ff6abf92b3219e
    book metadata
    content sha256
    109a38ded81df21b4d2d2370966964434d1ae50aa862ca446a206df1ddda2c36
    document type
    citation
    dois
    1. 10.1002/jso.27205
    electronic publication date
    display
    2023 Feb 13
    precision
    day
    year
    2023
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:36779385
    immutable id
    pubmed:36779385@109a38ded81df21b4d2d2370966964434d1ae50aa862ca446a206df1ddda2c36
    journal
    abbreviation
    J Surg Oncol
    issn electronic
    1096-9098
    issn print
    0022-4790
    issue
    5
    name
    Journal of surgical oncology
    nlm unique id
    0222643
    pages
    871-881
    volume
    127
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      36779385
      provenance
      batch id
      d370e99271168e8a8a13
      provider
      NCBI PubMed ESummary
      record sha256
      4f4cf7be1abe8e624128d628b6cf6aea6dce630118048fc80fc352b320808edf
      response sha256
      f65ace3ceb1efa86f3fbab8e01ce265243e7c6b7f13c5f71c357c1f219ad79c4
      retrieved at
      2026-09-09T23:48:13.005737+00:00
      publication date
      display
      2023 Apr
      precision
      month
      year
      2023
      publication types
      1. Journal Article
      2. Randomized Controlled Trial
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/36779385/
      title
      Neoadjuvant pazopanib in nonrhabdomyosarcoma soft tissue sarcomas (ARST1321): A report of major wound complications from the Children's Oncology Group and NRG Oncology.

      Preserved source evidence · Not medical advice